| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.11B | +28.8% |
| Cost of Revenue | $946.1M | +31.2% |
| R&D Expense | $21.4M | +8.3% |
| SG&A Expense | $89.6M | +58.9% |
| Operating Income | $22.1M | -48.2% |
| Interest Expense | $10.4M | -21.8% |
| Pre-tax Income | -$111.1M | -572.6% |
| Income Tax | -$137.8M | — |
| Net Income | $25.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.9M | +8.3% |
| Accounts Receivable | $123.0M | -13.9% |
| Current Assets | $174.4M | -8.2% |
| Total Assets | $383.8M | +46.3% |
| Current Liabilities | $147.6M | +11.1% |
| Long-term Debt | $153.4M | -5.6% |
| Total Liabilities | $413.0M | +33.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $65.6M | +43.0% |
| Capital Expenditures | $340K | +33.9% |
| Investing Cash Flow | -$340K | +48.0% |
| Financing Cash Flow | -$61.6M | -220.7% |
| Free Cash Flow | $65.3M | +43.1% |
| +54.1% |
| EPS (Basic) | $0.46 | +48.4% |
| EPS (Diluted) | $0.39 | +25.8% |
| Stockholders' Equity |
| $4.2M |
| +74.9% |